A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)
Clinical trial NCT04237116 · TERMINATED
Trial details
- NCT number
- NCT04237116
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2021-06-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.